Characteristics and Management of a Cohort of Patients with Asymmetric Thyroid Eye Disease and Unilateral Dysthyroid Optic Neuropathy Undergoing Unilateral Orbital Decompression Surgery
- 1Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria
- 2Department of Oral and Maxillofacial Surgery, Medical University of Vienna, 1090 Vienna, Austria
Abstract
Background/Objectives: The aim was to describe the clinical characteristics and report the long-term outcomes of a cohort of patients with asymmetric thyroid eye disease (TED), including a subgroup with unilateral dysthyroid optic neuropathy (DON), treated with unilateral orbital decompression surgery alone or in combination with intravenous (IV) methylprednisolone. Methods: This retrospective study included 48 patients with asymmetric TED who all underwent orbital decompression with or without IV corticosteroid therapy between 2006 and 2020 at the Department of Ophthalmology and Optometry and Oral and Maxillofacial Surgery of the Medical University of Vienna, Austria. Results: The mean follow-up was 4.6 ± 2.6 years. Overall, 52% of the patients initially received IV corticosteroids followed by orbital decompression, and 73% underwent three-wall decompression. Mean visual acuity (VA) was 0.1 ± 0.5 logMAR at baseline and 0.1 ± 0.5 logMAR at final follow-up (p = 0.4). The mean reduction in proptosis was 4 ± 3 mm. Unilateral DON was diagnosed in 50% of the patients. In this subgroup, 67% were initially treated with IV corticosteroids and 79% underwent three-wall decompression. Mean reduction in proptosis was 5 mm. The final VA of the affected eye was <0.3 logMAR in 88% (21/24) of the patients with unilateral DON. Conclusions: Patients with asymmetric TED were predominantly treated with IV corticosteroids and received three-wall orbital decompression. Visual function could be maintained in a high number of cases with asymmetric TED and patients with unilateral DON.
Related
- Teprotumumab-associated persistent unilateral hearing loss in dysthyroid optic neuropathy: a case report with review of the literature
- Clinical Outcomes and Feasibility of Unilateral Biportal Endoscopic Decompression for Thoracic Ossification of the Ligamentum Flavum: A Retrospective Single-Center Study
- Changes in spinopelvic sagittal parameters and functional outcomes after unilateral microscopic decompression for lumbar spinal stenosis
- Unilateral laminotomy with bilateral decompression versus standard open bilateral decompression in patients with single-level lumbar spinal stenosis without instability: a single-center retrospective cohort study
- Unilateral Biportal Endoscopy Versus Percutaneous Endoscopic Interlaminar Discectomy for Highly Migrated Lumbar Disc Herniation: A Retrospective Comparative Study With Quantitative MRI-Based Decompression Analysis.
BibTeX
@article{rezardreindl2026characteristics,
title = {{Characteristics and Management of a Cohort of Patients with Asymmetric Thyroid Eye Disease and Unilateral Dysthyroid Optic Neuropathy Undergoing Unilateral Orbital Decompression Surgery}},
author = {Sandra Rezar-Dreindl and Lorenz Wassermann and Johannes Engelmann and Thomas Neumayer and Stefan Sacu and Eva Stifter},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218726},
url = {https://www.mdpi.com/2077-0383/15/21/8726},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Characteristics and Management of a Cohort of Patients with Asymmetric Thyroid Eye Disease and Unilateral Dysthyroid Optic Neuropathy Undergoing Unilateral Orbital Decompression Surgery
AU - Sandra Rezar-Dreindl
AU - Lorenz Wassermann
AU - Johannes Engelmann
AU - Thomas Neumayer
AU - Stefan Sacu
AU - Eva Stifter
PY - 2026
DA - 2026/11/08
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218726
UR - https://www.mdpi.com/2077-0383/15/21/8726
AB - Background/Objectives: The aim was to describe the clinical characteristics and report the long-term outcomes of a cohort of patients with asymmetric thyroid eye disease (TED), including a subgroup with unilateral dysthyroid optic neuropathy (DON), treated with unilateral orbital decompression surgery alone or in combination with intravenous (IV) methylprednisolone. Methods: This retrospective study included 48 patients with asymmetric TED who all underwent orbital decompression with or without IV corticosteroid therapy between 2006 and 2020 at the Department of Ophthalmology and Optometry and Oral and Maxillofacial Surgery of the Medical University of Vienna, Austria. Results: The mean follow-up was 4.6 ± 2.6 years. Overall, 52% of the patients initially received IV corticosteroids followed by orbital decompression, and 73% underwent three-wall decompression. Mean visual acuity (VA) was 0.1 ± 0.5 logMAR at baseline and 0.1 ± 0.5 logMAR at final follow-up (p = 0.4). The mean reduction in proptosis was 4 ± 3 mm. Unilateral DON was diagnosed in 50% of the patients. In this subgroup, 67% were initially treated with IV corticosteroids and 79% underwent three-wall decompression. Mean reduction in proptosis was 5 mm. The final VA of the affected eye was <0.3 logMAR in 88% (21/24) of the patients with unilateral DON. Conclusions: Patients with asymmetric TED were predominantly treated with IV corticosteroids and received three-wall orbital decompression. Visual function could be maintained in a high number of cases with asymmetric TED and patients with unilateral DON.
SN - 2077-0383
ER -